|
News Advisory
Note To Reporters and Editors:
National Cancer Institute Hosts Session
on New Developments in Nanotechnology
|
| What: |
Please join us to discuss new developments
in nanotechnology in cancer. The session will include a review
of nanotechnology, how it is affecting research, and accelerating
the development of new diagnostics and therapies. Speakers
will include NCI leadership, as well as biologists, engineers
and physicians who are members of the NCI Alliance for Nanotechnology
in Cancer, an initiative to accelerate the application of
nanotechnology to cancer research and patient care. Among
the featured speakers will be scientists discussing their
work in delivery, imaging and therapeutics. |
| Who: |
Anna D. Barker, Ph.D. (NCI):NCI
Alliance for Nanotechnology in Cancer: Catalyst for Transformation
Thomas A. Kalil (University of California, Berkeley): Nanotechnology
Policy Development: Regional and National Initiatives
Sanjiv Gambhir, M.D., Ph.D. (Stanford University): Molecular
Imaging in Living Subjects: Shining a New Light on Cancer
Diagnostics
Sadik Esener, Ph.D. (University of California, San
Diego): Multi-compartment Delivery Vehicles: Novel
Approaches for Targeted Therapies
Delivery Vehicles in Targeted Therapies: All Aboard the “Motherships”
James Heath, Ph.D. (California Institute of Technology): Detecting
the Impossible: Cancer Candidate Biomarkers and Capture Agents
Scott McNeil, Ph.D. (NCI): Preclinical Characterization
of Nanoparticles Intended for Medical Applications |
| When: |
Wednesday, October 25, 2006: 12:15-1:30
p.m. PDT |
| Where: |
Marina del Rey Room, San Diego Marriott La
Jolla
4240 La Jolla Village Drive
La Jolla, California 92037
Directions and map:
http://marriott.com/property/mapandnearbyairports/default.mi?marshaCode=sanlj
If you cannot attend in person, the audio portion of the
media session is available to reporters via a toll-free
conference line at 866-755-5928, conference ID #9241089.
Slides presented during the session can be viewed live,
on-line at http://nihbreeze.cit.nih.gov/nanomedia/.
To access the slides, use the “enter as guest” option.
The session will begin promptly at 12:15 p.m. PDT. Reporters
should dial in and log on 5-10 minutes before the start of
the conference. Following the presentations, an operator
will inform callers that the session is open to questions.
To ask a question, press “*1” on your touchtone phone. You
will hear a tone to indicate your question is pending. |
|
For more information on the NCI Alliance for Nanotechnology in Cancer,
please visit http://nano.cancer.gov.
For more information about cancer, please visit the NCI Web site at http://www.cancer.gov or
call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and
is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic,
clinical and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit www.nih.gov.
|
